0 63

Cited 0 times in

Intra-articular Injections of Hyaluronic Acid on Osteochondral Lesions of the Talus After Failed Arthroscopic Bone Marrow Stimulation

DC FieldValueLanguage
dc.contributor.author박광환-
dc.contributor.author이진우-
dc.contributor.author한승환-
dc.date.accessioned2021-01-19T07:49:34Z-
dc.date.available2021-01-19T07:49:34Z-
dc.date.issued2020-11-
dc.identifier.issn1071-1007-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/181340-
dc.description.abstractBackground: The purpose of the study was to compare clinical and functional outcomes before and after hyaluronic acid (HA) injections in patients with osteochondral lesions of the talus who experienced a failure of their primary treatment with arthroscopic microfracture surgery. Methods: A total of 40 patients were included in the final study. These patients had received microfracture surgery but continued to experience postoperative pain over an average of 13.0 months (range, 0-81 months) and were available for investigation with a mean follow-up for 29.1 months (SD 14.7; range 2.6-79.6 months). All patients received intra-articular injections of HA once per week for 3 weeks. We assessed clinical and functional outcomes before and after injection using the American Orthopaedic Foot & Ankle Society (AOFAS) score, Foot and Ankle Outcome Score (FAOS), Short Form Health Survey (SF-36), the visual analog scale (VAS) for pain, and the Alexander subjective scale. Results: The AOFAS score significantly increased from 50.7 ± 13.8 to 79.9 ± 13.8 and the FAOS scores for symptom, pain, daily living, and sports were significantly higher postinjection compared to preinjection (all P < .001). Similarly, the mean VAS for pain was significantly decreased after 6 weeks following injection and continued to decrease over the follow-up period; the mean VAS was significantly lower postinjection compared to preinjection at 12 months (P < .001). Conclusion: Intra-articular HA injections on average significantly improved clinical and functional scores after failed primary operative treatment. HA injections may provide an alternative to secondary operative treatment and provide better clinical outcomes than other conservative treatments. Level of evidence: Level II, prospective observational cohort study.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherSage Publications-
dc.relation.isPartOfFOOT & ANKLE INTERNATIONAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleIntra-articular Injections of Hyaluronic Acid on Osteochondral Lesions of the Talus After Failed Arthroscopic Bone Marrow Stimulation-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Orthopedic Surgery (정형외과학교실)-
dc.contributor.googleauthorYeok Gu Hwang-
dc.contributor.googleauthorJin Woo Lee-
dc.contributor.googleauthorKwang Hwan Park-
dc.contributor.googleauthorChang Hsienhao-
dc.contributor.googleauthorSeung Hwan Han-
dc.identifier.doi10.1177/1071100720945944-
dc.contributor.localIdA01437-
dc.contributor.localIdA03230-
dc.contributor.localIdA03230-
dc.contributor.localIdA04305-
dc.contributor.localIdA04305-
dc.relation.journalcodeJ00902-
dc.identifier.eissn1944-7876-
dc.identifier.pmid32844669-
dc.identifier.urlhttps://journals.sagepub.com/doi/10.1177/1071100720945944-
dc.subject.keywordarthroscopic bone marrow stimulation-
dc.subject.keywordhyaluronic acid-
dc.subject.keywordmicrofracture-
dc.subject.keywordosteochondral lesions of the talus-
dc.contributor.alternativeNamePark, Kwang Hwan-
dc.contributor.affiliatedAuthor박광환-
dc.contributor.affiliatedAuthor이진우-
dc.contributor.affiliatedAuthor이진우-
dc.contributor.affiliatedAuthor한승환-
dc.contributor.affiliatedAuthor한승환-
dc.citation.volume41-
dc.citation.number11-
dc.citation.startPage1376-
dc.citation.endPage1382-
dc.identifier.bibliographicCitationFOOT & ANKLE INTERNATIONAL, Vol.41(11) : 1376-1382, 2020-11-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Orthopedic Surgery (정형외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.